A risk analysis for production processes with disposable bioreactors.

Area of Science:

• Pharmaceutical Manufacturing
• Biotechnology
• Quality Management Systems

Background:

• Current quality management systems (QMS) focus on maintaining existing processes and compliance.
• Advances in biotechnology and single-use manufacturing present new challenges for drug production.
• Existing quality standards are insufficient for novel biotechnological products, necessitating new safety measures.

Purpose of the Study:

• To address the challenges in quality management posed by new biotechnologies and single-use manufacturing.
• To propose a risk-management-based framework for qualification, validation, and manufacturing procedures.
• To enhance patient safety in pharmaceutical production utilizing advanced methods.

Main Methods:

• Review of regulatory background for medicinal product manufacturing.
• Exploration of key risk management methodologies.
• Identification and evaluation of hazards associated with single-use equipment in pharmaceutical production (bioreactors, storage containers, connectors).

Main Results:

• Established criteria for risk evaluation in pharmaceutical manufacturing.
• Detailed analysis of hazards linked to single-use systems.
• Presented aspects of industrial application for quality risk management.

Conclusions:

• A risk-management-based approach is crucial for adapting quality management to new biotechnologies.
• Qualification, validation, and manufacturing procedures must be re-evaluated using risk management principles.
• Proactive risk assessment and management are essential for ensuring patient safety with innovative drug production.